Discovery of PD-L1 inhibitors featuring novel indole and pyrrolopyridine scaffolds with PD-L1 degradation activity in vivo
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.109477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Xuewen Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutic…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Antineoplastic Agents, Indoles, Pyridines. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Southern Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
To broaden the structural diversity of contemporary small molecule PD-L1 inhibitors, we rationally designed and synthesized a novel series of PD-L1 targeting compounds based on the structural features of the known lead compound 24, incorporating indole and pyrrolopyridine scaffolds. Among these, compound Z38 emerged as the most potent candidate, with a half maximal inhibitory concentration (IC₅₀) of 110 nM against PD-L1 and significantly lower cytotoxicity than the lead compound. Z38 exerted dose dependent immunomodulatory effects in a HepG2/Jurkat T cell coculture system, promoting HepG2 cell death by restoring T cell mediated antitumor immunity. In B16-F10 melanoma bearing mice, intraperitoneal administration of Z38 (30 mg/kg) achieved a tumor growth inhibition rate (TGI) of 60 % without detectable organ toxicity. Mechanistically, Z38 activated the tumor immune microenvironment by increasing tumor infiltrating lymphocytes (TILs) and inducing ∼50 % PD-L1 degradation in tumor tissues. This work identifies Z38 as a structurally distinct, low toxicity PD-L1 inhibitor with robust in vitro and in vivo antitumor efficacy, offering a promising lead for further development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
- The Seventh Affiliated Hospital, Southern Medical University, Foshan 528244, China.
- Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; Dep…
- Department of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: 252199453@qq.com.
- Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450046, China. Electronic address: wzj95cpu@163.com.
- Engineering Research Center of Tropical Medicine Innovation and Transformation of Ministry of Education, International Joint Research Center of Human-Machine Intelligent Collaborative for Tumor Precision Diagnosis and T…
Förderung
- Southern Medical University
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Zhang, L., Sun, Z., Xu, C., Tan, J., Ren, Y., Zhang, J., Chen, T., Wang, Z., Kong, D., & Chen, J. (2026). Discovery of PD-L1 inhibitors featuring novel indole and pyrrolopyridine scaffolds with PD-L1 degradation activity in vivo. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.109477
Vancouver
Zhang X, Zhang L, Sun Z, Xu C, Tan J, Ren Y, et al. Discovery of PD-L1 inhibitors featuring novel indole and pyrrolopyridine scaffolds with PD-L1 degradation activity in vivo. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.109477
BibTeX
@article{Zhang2026,
author = {Zhang, Xuewen and Zhang, Lirong and Sun, Zhiqiang and Xu, Chenglong and Tan, Jiamin and Ren, Yichang and Zhang, Jian and Chen, Ting and Wang, Zhijie and Kong, Dulin and Chen, Jianjun},
title = {Discovery of PD-L1 inhibitors featuring novel indole and pyrrolopyridine scaffolds with PD-L1 degradation activity in vivo},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.109477}
}
EUVIMED